Specialised CF care has led to a dramatic improvement in survival in CF: in the last four
decades, well above what was seen in the general population over the same period. With the …

Developments in managing CF continue to drive dramatic improvements in survival. As
newborn screening rolls-out across Europe, CF centres are increasingly caring for cohorts of …

The taxonomic position of members of the Mycobacterium abscessus complex has been the
subject of intensive investigation and, in some aspects confusion, in recent years as a result …

Although new inhaled antibiotics have profoundly improved respiratory diseases in cystic
fibrosis (CF) patients, lung infections are still the leading cause of death. Inhaled antibiotics, ie, …

Background Pseudomonas aeruginosa chronic pulmonary infection is an unfavourable
event in cystic fibrosis. Bacterial clearance is possible with an early antibiotic treatment upon …

Cystic fibrosis (CF) is a genetic disease resulting in chronic polymicrobial infections of the
airways and progressive decline in lung function. To gain insight into the underlying causes of …

Background Staphylococcus aureus is an opportunistic pathogen and a leading cause of
nosocomial infections. It can acquire resistance to all the antibiotics that entered the clinics to …

Background Chronic infection with Pseudomonas aeruginosa is a major cause of morbidity
and mortality in cystic fibrosis (CF) patients, and a more complete understanding of P. …

Objective We evaluated the prevalence, Cystic Fibrosis Transmembrane Conductance
Regulator (CFTR) gene profile, clinical data, management and outcome for infants with a CFTR-…

… Clelia Di Serio, Antonio Manca, Giovanna Pizzamiglio, Paola MV Rancoita, Gian Maria
Rossolini, Giovanni Taccetti, Antonio Teri, Stefan Niemann, Daniela M. Cirillo …